This is a routine 10b5-1 plan filing by an officer; no material impact expected. Monitor for any deviation from the plan or acceleration of sales, but the filing itself does not warrant action.
Price Chart
Executive Summary
Jeremy Chadwick, an officer of Kymera Therapeutics, filed a Form 144 on May 26, 2026, indicating intent to sell 13,130 shares of common stock valued at approximately $1.04 million. The shares were acquired through vesting of restricted stock units, and Chadwick has been executing sales under a 10b5-1 plan, with prior sales totaling over $14 million since March 2026. The filing is a routine advance notice under a pre-arranged trading plan and does not signal a change in business fundamentals.
Key Facts
- Officer Jeremy Chadwick filed Form 144 to sell 13,130 shares of common stock.
- Estimated aggregate market value of the proposed sale is $1,035,825.70 based on a filing date of May 26, 2026.
- Chadwick has been selling shares under a 10b5-1 plan, with prior sales totaling approximately $14.2 million from March to April 2026.
- Shares to be sold were acquired upon vesting of restricted stock units between March 2025 and May 2026.
- The filing is an advance notice of intent to sell, not a completed transaction.
Financial Impact
Proposed sale of 13,130 shares valued at ~$1.04 million, representing a small fraction of the $6.5B market cap.
Risk Factors
- Insider selling under a 10b5-1 plan is pre-arranged and not indicative of negative outlook.
- No material risk to company fundamentals from this filing.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 144 Filing (Primary) | 0001950047-26-005075 |
| Document: 0001950047-26-005075-index.html | 0001950047-26-005075 |
| Document: 0001950047-26-005075.txt | 0001950047-26-005075 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Aug 5, 2026 8w ago | 8-K | $105.48 $118.63 | ▲ +12.47% | ▲ +13.07% | $107.39 (+1.81%) |
Jul 8, 2026 12w ago | Insider Cluster | $114.16 $105.48 | ▲ +7.60% | ▲ +10.88% | $107.39 (+5.93%) |
Jul 2, 2026 13w ago | Insider Cluster | $113.51 $107.01 | ▲ +5.73% | ▲ +5.31% | $107.39 (+5.39%) |
Jul 2, 2026 13w ago | Insider Cluster | $113.51 $107.01 | ▲ +5.73% | ▲ +5.31% | $107.39 (+5.39%) |
Jun 30, 2026 13w ago | 144 | $114.20 $105.25 | ▲ +7.84% | ▲ +5.65% | $107.39 (+5.96%) |
Jun 29, 2026 13w ago | 144 | $114.67 $110.05 | ▼ −4.03% | ▼ −3.00% | $107.39 (−6.35%) |
Jun 26, 2026 13w ago | Insider Cluster | $109.32 $110.57 | ▼ −1.14% | ▼ −1.42% | $107.39 (+1.77%) |
Jun 26, 2026 13w ago | 144 | $109.32 $110.57 | ▼ −1.14% | ▼ −1.42% | $107.39 (+1.77%) |
Jun 26, 2026 13w ago | 144 | $109.32 $110.57 | ▼ −1.14% | ▼ −1.42% | $107.39 (+1.77%) |
Jun 24, 2026 14w ago | 144 | $116.46 $110.38 | ▼ −5.22% | ▼ −5.75% | $107.39 (−7.79%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access